|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Foundation Trusts (England) - Chief Executive
- NHS Trusts (England) - Medical Director
- NHS Trusts (England) - Chief Executive
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- CMO Urgent Messages - Non-NHS Recipients on Public Health Link
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Consultants in Communicable Diseases
- CMO Urgent Messages - Recipients on Public Health Link
- Director of Public Health
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- Primary Care Networks
|
Action category: |
|
Important information for immediate action
|
Title: |
|
Evidence of harm from illicit or fake benzodiazepines
|
Broadcast content: |
|
The attached alert advises of the availability of, and harm from, illicit drugs sold as benzodiazepines particularly when used in conjunction with alcohol and drugs with a respiratory depressant effect including gabapentinoids and opioids.
|
Additional information: |
|
NHS England and NHS Improvement Regional Offices: please cascade this alert to Community Pharmacy. Directors of Public Health please cascade to: - Commissioners and providers of drug treatment and prevention services - Other relevant services that have, or may have, contact with drug users including: sexual health services; youth services; hostels; relevant information networks and service users groups
|